After completing this education activity, the learner will be able to initiate proactive measures and provide targeted patient education to prevent adverse events associated with these drugs.
Contact hours available until 12/31/22.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation.
Authors Conflict of Interest Disclosure:
The author(s), editor, editorial committee, content reviewers, and education director reported no actual or potential conflict of interest in relation to this continuing nursing education article.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
This education activity is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Academy of Medical-Surgical Nurses (AMSN).
Anthony J Jannetti, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Anthony J. Jannetti, Inc. is an approved provider of continuing nursing education by the California Board of Registered Nurses, Provider Number CEP 5387.
This article was reviewed and formatted for contact hour credit by Michele Boyd, MSN, RN, NPD-BC, AMSN Education Director.
You must be logged in and own this product in order to post comments.
Great article, direct and to the point, very informative.
Very informative article.
Very good article, informative.
The information on the Factor Xa inhibitors is appreciated. This is the newest generation of anti-coagulants that we are using in the acute care setting.
It was a great article. Thank you!
I learned that the newer anticoagulants are much safer than Warfarin, however, more research is needed to determine how safe they are with continued long term usage.
Great article, eye opener. The problem remains, cost. It is a barrier with patients and no insurance.THANKS
I enjoyed reading this article as we are frequently giving oral anticoagulants to patients. Very good information!
Direct-acting oral anticoagulants are among the most common medications administered by clinical medical-surgical nurses. Proactive measures and targeted patient education should be encouraged to prevent adverse events associated with these drugs. Literature and treatment guidelines reviewed and discussed in this article will provide nurses with additional information on safe administration of DOACs
I found this article to be almost a duplicate of information in "Stroke Prevention in Patients with Atrial Fibrillation" MSNJ2123 Had common authors. Having said that, the information is very easy to comprehend and share.
Anticoagulation's are always important and interesting to read about and stay updated on.
We administer this to a lot of patients since I work on a telemetry floor. The article is a great refresher course and really emphasizes the need for patient education especially at discharge.